{
    "2021-11-30": [
        [
            {
                "time": "2021-12-01",
                "original_text": "U.S. administers 460.7 mln doses of COVID-19 vaccines - CDC",
                "features": {
                    "keywords": [
                        "vaccines",
                        "CDC",
                        "doses"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "Johnson & Johnson Announces Significant Progress Towards Its Climate Goals - 100% Renewable Electricity for All Sites in the United States, Canada and Europe by 2023",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "climate goals",
                        "renewable electricity"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "environment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "Moderna CEO says vaccines likely less effective against Omicron COVID-19 variant",
                "features": {
                    "keywords": [
                        "Moderna",
                        "Omicron",
                        "less effective"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "Omicron: 'Time will tell' as we learn more about transmissibility and risk, doctor explains",
                "features": {
                    "keywords": [
                        "Omicron",
                        "transmissibility",
                        "risk"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "'The market doesn't like an information vacuum, and now we have two,' strategist says",
                "features": {
                    "keywords": [
                        "market",
                        "information vacuum",
                        "strategist"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "UPDATE 1-Slovenia set to ban Janssen vaccine after woman's death",
                "features": {
                    "keywords": [
                        "Slovenia",
                        "Janssen",
                        "ban",
                        "death"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?",
                "features": {
                    "keywords": [
                        "stocks",
                        "underperformed",
                        "buy"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "‘We can’t have countries lingering at 10%' COVID-19 vaccination, Columbia professor explains",
                "features": {
                    "keywords": [
                        "countries",
                        "lingering",
                        "vaccination"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "J&J (JNJ) to Explore Omicron Version of its COVID Vaccine",
                "features": {
                    "keywords": [
                        "J&J",
                        "Omicron",
                        "vaccine"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "Stocks fall as investors try to gauge Omicron risk, ongoing supply chain issues",
                "features": {
                    "keywords": [
                        "stocks",
                        "fall",
                        "investors",
                        "Omicron",
                        "supply chain"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "Market strategist: Investors ‘don’t want to overreact’ amid Omicron uncertainty",
                "features": {
                    "keywords": [
                        "market",
                        "strategist",
                        "investors",
                        "overreact",
                        "Omicron"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "REFILE-UPDATE 3-S.Africa's Aspen signs deal paving way for J&J COVID vaccine licence",
                "features": {
                    "keywords": [
                        "S.Africa",
                        "Aspen",
                        "J&J",
                        "vaccine",
                        "licence"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}